SCHEMBL24264342

SCHEMBL24264342

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccc(-c5cccc6oc7ccccc7c56)cc34)nc(-c3cccc4sc5ccccc5c34)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.33
LIMK1 P53667 1/20 0.33
ALOX5 P09917 2/20 0.32
CHEK2 O96017 1/20 0.32
HCRTR1 O43613 1/20 0.32
BRDT Q58F21 1/20 0.32
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
PLA2G10 O15496 1/20 0.31
MMP12 P39900 1/20 0.31
AHR P35869 2/20 0.30
MEN1 O00255 2/20 0.30
ALDH1A1 P00352 2/20 0.30
KMT2A Q03164 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
BACE1 P56817 1/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24264145 1.00 PRKDC (0.33) PRKDCLIMK1ALOX5CHEK2HCRTR1
SCHEMBL23822326 1.00 PRKDC (0.33) PRKDCLIMK1ALOX5CHEK2HCRTR1
SCHEMBL23822340 0.97 PRKDC (0.35) PRKDCLIMK1ALOX5HCRTR1BRDT
SCHEMBL24264148 0.97 PRKDC (0.35) PRKDCLIMK1ALOX5CHEK2HCRTR1
SCHEMBL23822339 0.96 PRKDC (0.33) PRKDCLIMK1ALOX5CHEK2HCRTR1
SCHEMBL24264149 0.96 PRKDC (0.35) PRKDCLIMK1ALOX5CHEK2HCRTR1
SCHEMBL24264153 0.96 PRKDC (0.35) PRKDCLIMK1ALOX5CHEK2HCRTR1
SCHEMBL25581188 0.95 PRKDC (0.34) PRKDCALOX5CHEK2HCRTR1BRDT
SCHEMBL24264256 0.95 PLA2G2A (0.35) PRKDCALOX5CHEK2HCRTR1BRDT
SCHEMBL24216811 0.95 PRKDC (0.36) PRKDCLIMK1ALOX5CHEK2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, TRPC1, CYP1A1 PRKDC 4335/4885LIMK1 331/4885ALOX5 1152/4885
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, TRPC1, CYP1A1 PRKDC 4335/4885LIMK1 331/4885ALOX5 1152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.